Allergic asthma
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Meet the western medical diagnostic criteria for mild to moderate allergic asthma; (2) Aged 60 years and above; (3) Voluntary participation and signing an informed consent form; (4) Those with low literacy or reading difficulties but who could understand the entries correctly with the investigator's explanation and who had obtained the informed consent of their guardians.
Exclusion criteria
Exclusion criteria: (1) Patients with comorbid chronic obstructive pulmonary disease (COPD) bronchiectasis and allergic bronchopulmonary aspergillosis (ABPA); (2) Hypersensitivity to the components of traditional Chinese medicine or budesonide/formoterol; (3) Patients who have received systemic allergen-specific immunotherapy within 1 year prior to enrolment; (4) Those with co-morbidities of malignant tumours haematological disorders psychiatric disorders or severe hepatic or renal insufficiency; (5) Those who are unable to complete auxiliary examinations such as pulmonary function tests FeNO and blood tests; (6) Participating in other drug clinical trials at the same time.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Asthma Control Test; | — |
Secondary
| Measure | Time frame |
|---|---|
| Constitution in Chinese medicine questionnaire;Asthma Control Test;IgE and sIgE;ACQ-5/ACQ-7;The fraction of exhaled nitric oxide;Asthma Quality of Life Questionnaire;lung function testing;the total dose of budesonide-formoterol and Total Asthma Symptom Score; | — |
Countries
China
Contacts
Hubei Provincial Hospital of Traditional Chinese Medicine